Monsanto still 'open' to deal with German chemical giant

AFP - [email protected]
Monsanto still 'open' to deal with German chemical giant
An Indian Monsanto farmer seen at work in 'Sweet Corn' field at Monsanto Bangalore Centre. Photo: EPA.

Monsanto said on Wednesday it was still open to a potential merger with Bayer, or to another big deal, as it reported lower earnings due to a tough agricultural market.


One month after the US seed and pesticide maker rejected a $62 billion takeover bid by Germany's Bayer AG as too low, Monsanto chief executive Hugh Grant said he had held talks with Bayer and with other unspecified companies.

"While there is no formal update on the Bayer proposal, I have been personally in discussions with Bayer's management over the last several weeks, along with others regarding alternative strategic options," Grant said in a statement announcing the company's latest quarterly earnings.

"We continue to recognize the potential value these types of combinations can create as they accelerate innovation and increase choice for farmers across a broader set of crops, geographies and production practices, while improving the sustainability of agriculture around the world," he said.

A takeover by Bayer would have been the biggest takeover by a German group of a foreign company and would create a new world leader in seeds, pesticides and genetically modified (GM) crops.

But German environmentalists worry about the impacts of the tie-up, with some telling AFP in the past that it would be "disastrous and diabolical." 

"The biggest fear is that Bayer is seeking to buy Monsanto to inundate the European market with GM crops," said Anne Isakowitsch, a Berlin-based activist for the environmentalist campaign group, Sum of Us, who has launched a petition against the tie-up.

The Bayer-Monsanto dance comes in the wake of announced proposed megamergers involving US companies DuPont and Dow Chemical and Swiss company Syngenta and ChemChina as low crop prices depress demand for many agricultural products.

The deals have sparked worries among farmers who fear that consolidation will lead to higher prices for seeds. Some analysts have said a Bayer-Monsanto tie-up could face tough scrutiny from antitrust regulators.

Monsanto reported on Wednesday a 37.2 percent drop in fiscal third-quarter earnings to $717 million after sales tumbled 8.5 percent to $4.2 billion. Key factors included the pricing declines in herbicide glyphosate, known by its brand name Roundup.

"Our industry is running at a low point in the overall agriculture cycle and we've experienced an unforeseen level of challenges affecting our business in fiscal year 2016," Grant said.

"Today, however, we anticipate positive resolution on the horizon for several of these challenges, coupled with early signs of recovery in agriculture."

Shares of Monsanto rose 1.5 percent to $102.65 in late-morning trade.



Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also